The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis-Reference-Cited by-同舟云学术

The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis

Published:2015-07-29 Issue:3 Volume:173 Page:842-845
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Capriotti K.¹,Capriotti J.A.²,Lessin S.¹,Wu S.³⁴,Goldfarb S.⁵,Belum V.R.⁶,Lacouture M.E.⁶

Affiliation:

1. Bryn Mawr Skin and Cancer Institute; Rosemont PA U.S.A

2. Ophthalmology Consultants PC; Juan F. Luis Hospital; Christiansted VI U.S.A

3. Division of Medical Oncology; Department of Medicine; State University of New York at Stony Brook; Stony Brook NY U.S.A

4. Division of Hematology and Oncology; Department of Medicine; Northport VA Medical Center; Northport NY U.S.A

5. Breast Cancer Medicine Service; Memorial Sloan Kettering Cancer Center; New York NY U.S.A

6. Dermatology Service; Memorial Sloan Kettering Cancer Center; New York NY U.S.A

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.13743/fullpdf

Reference13 articles.

1. Paclitaxel Approved Indications and Dosages. FDA Label: Taxol (Paclitaxel) Princeton, NJ Bristol-Myers Squibb Company 1992 http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020262s049lbl.pdf

2. Docetaxel Approved Indications and Dosages. FDA Label: Taxotere (Docetaxel) Bridgewater, NJ Aventis Pharmaceuticals Inc. 2004 http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/020449s028lbl.pdf

3. Nab-Paclitaxel Approved Indications and Dosages. FDA Label: Abraxane (Paclitaxel Nanoparticle Albumin-Bound) Summit, NJ Celgene Corporation 2005 http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021660s037lbl.pdf

4. Mechanism of action of antitumor drugs that interact with microtubules and tubulin;Jordan;Curr Med Chem Anticancer Agents,2002

5. The irreplaceable image: nail changes in onco-hematologic patients;Vassallo;Haematologica,2001

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Questionnaire survey of healthcare professionals on taxane-induced nail change in Japan;Supportive Care in Cancer;2024-09-10

2. Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison;Supportive Care in Cancer;2024-07-27

3. hsa‑miR‑455‑3P as a predictive biomarker of anemia in patients with non‑small cell lung cancer treated with carboplatin plus paclitaxel;Oncology Letters;2024-03-21

4. Questionnaire survey of Healthcare Professionals on Taxane-Induced Nail Change in Japan;2024-02-07

5. Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy+Abiraterone/Prednisone and Androgen Deprivation Therapy+Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer;The World Journal of Men's Health;2024